Illumina Says It Was Second Bidder for Complete Genomics

Illumina Says It Was Second Bidder for Complete Genomics
BGI-Shenzhen, a Chinese operator of genome-sequencing centers, agreed to acquire Complete Genomics in September for $ 3.15 a share, or about $ 117.6 million, to expand in the U.S. market for medical and research DNA testing. The board of Complete …
Read more on Bloomberg

Leave a Reply